Azimuth Capital Investment Management LLC Acquires 2,713 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Azimuth Capital Investment Management LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 42,232 shares of the medical equipment provider's stock after buying an additional 2,713 shares during the quarter. Intuitive Surgical accounts for about 0.9% of Azimuth Capital Investment Management LLC's investment portfolio, making the stock its 27th largest position. Azimuth Capital Investment Management LLC's holdings in Intuitive Surgical were worth $22,043,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of ISRG. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares in the last quarter. Geode Capital Management LLC grew its position in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the period. Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $2,401,493,000. Finally, Invesco Ltd. boosted its position in shares of Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after buying an additional 295,025 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last three months. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 0.1 %

Shares of Intuitive Surgical stock traded down $0.35 during mid-day trading on Monday, reaching $493.25. 373,009 shares of the stock were exchanged, compared to its average volume of 1,595,602. The company has a market cap of $175.69 billion, a price-to-earnings ratio of 76.95, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a 50-day simple moving average of $532.72 and a 200 day simple moving average of $532.68.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ISRG. Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Truist Financial decreased their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target on the stock. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.